|
| |
pipeline drugs antifibrinolytic Pages on BioPortfolio:
Results from other life science and pharmaceutical sites:
BioPortfolio BioCorporate Profile
continuously novel and promising pipeline. Presently, two of Thrombotargets most ... Drug Discovery. Phase 1. TT-112. Antifibrinolytic. Drug Discovery ...
http://www.bioportfolio.com/biocorporate/pdf/31064/thrombota...
|
Icatibant : Article : Nature Reviews Drug Discovery
Fresh from the Pipeline: Icatibant. Konrad Bork1, Uma Yasothan2 & Peter ... Attenuated androgens such as danazol and antifibrinolytic agents such as ...
http://www.nature.com/nrd/journal/v7/n10/full/nrd2694.html...
|
Thrombotargets Corporation relocates to Research Triangle Park in ...
TT-111 and TT-112 are two innovative antifibrinolytic compounds, having higher potency than currently commercialised antifibrinolytic drugs, which are being
...
http://www.bioportfolio.com/biotech_news/Thrombotargets_3.ht...
|
Drotrecogin alpha (activated) : Article : Nature Reviews Drug ...
Fresh from the Pipeline: Drotrecogin alpha (activated) ... thus reducing the inflammatory, procoagulant and antifibrinolytic response induced by thrombin.
...
http://www.nature.com/nrd/journal/v2/n1/full/nrd991.html...
|
BioPortfolio - ThromboTargets Corporation
Presently, two of Thrombotargets most innovative drug candidates, TT-103MH, ... Furthermore we have begun a new antifibrinolytic program (TT-111 and TT-112) ...
http://www.bioportfolio.com/biocorporate/31064-Thrombo_Targe...
|
DEPARTMENT OF HEALTH & HUMAN SERVICES
discusses three Xanodyne drugs, Methotrexate, Leucovorin, and Amicar, .... It ¡s used as an antifibrinolytic agent that acts to interrupt the process of ...
http://www.fda.gov/cder/warn/2002/10894.pdf...
|
Desmin 370 Opocrin SpA/Alfa Wassermann Dennis Mungall
by antifibrinolytic drugs such as EACA. The effects on post-phlebitic syndrome are quite .... 219795 Drug pipeline update - 1996 Alfa Wassermann SpA ...
http://www.biomedcentral.com/content/pdf/cd-387495.pdf...
|
Highlights of the World Allergy Congress, 2007
Antifibrinolytics also have prophylactic use, although they have fallen out of favor in the United States. .... RxTrials Institute Drug Pipeline Alert. ...
http://www.medscape.com/viewarticle/568217_1...
|
BioPortfolio - ThromboTargets Corporation - Profile
promising pipeline. Presently, two of Thrombotargets most innovative drug candidates, TT-103MH, a. novel antihemorrhagic human recombinant protein to be
use ...
http://www.bioportfolio.com/biocorporate/31064-ThromboTarget...
|
BioSpace - Thrombotargets Corporation News, Search Jobs, Events
Thrombotargets is an innovative drug discovery and development group of biotech ... Recently we begun a new antifibrinolytic program (TT-111 and TT-112) in ...
http://www.biospace.com/company_profile.aspx?CompanyId=10034...
|
|
